Israeli Drug Targets MS, Alzheimers, Crohns & Colitis
February 12, 2018
An Israeli scientists may have found a cure for some of the worst inflammatory diseases, affecting millions worldwide – with a single drug.
Despite groundbreaking medical developments, a cure for many some of the worst inflammatory diseases has yet to be found.
However, Prof. David Naor of the Hebrew University-Hadassah Medical School in Jerusalem says he may have discovered a new game-changing treatment with just one drug that targets several chronic inflammatory and neurodegenerative diseases, including multiple sclerosis, Alzheimer’s, rheumatoid arthritis, Crohn’s and colitis.
Each of these diseases affects millions of people worldwide.
Watch the video for more about this exciting news from Israel!
Similar posts
-
How Israel Helps Its Arab Neighbors
September 27, 2023Introduction Israel, a country known for its rich history and complex geopolitical landscape, ha...
-
The Amazing Country of Israel
September 15, 2023Introduction Nestled in the heart of the Middle East, Israel is a nation with a remarkable histo...
-
Israel Safeguards The World From Terror Attacks
August 23, 2023Introduction In an era where terrorism poses a significant threat to global security, Israel sta...
-
Israel Helps The World With Water Recycling
August 10, 2023Introduction In a world grappling with the challenges of water scarcity and resource management,...
-
Israel Empowers The World Through Innovation
July 10, 2023BY: SOLVE ISRAEL'S PROBLEMS Introduction:In recent years, Israel has emerged as a global powerho...
-
The Jerusalem Embassy, 5 Years Later
May 22, 2023By Nikki Haley On May 14, 2018, something incredible happened. The United States...
-
Israel's Fauda Top TV Show in Arab Countries
February 1, 2023Even some Arab countries without diplomatic relations with Israel are hooked on the action-packed d...
-
2.67 Million Tourists Visited Israel in 2022
January 10, 2023In a year of recovery from the corona crisis, domestic tourism records were broken, and foreign tou...
